Atypical endometrial hyperplasia in the conception of tumor progression (literature review)

Introduction. In recent years there has been an frequency increase of endometrial hyperplasia in the structure of gynecological morbidity. Atypical endometrial hyperplasia represents important clinical relevance in the basis of progression to endometrial cancer. There are significant contradictions in the interpretation of endometrial hyperplasia in modern classifications, which are differ from the data provided in ICD-10.

The aim of the study. This review aims to analyze the modern interpretation of endometrial hyperplasia in the concept of tumor progression.

Materials and methods. The analysis of PubMed, Embase, Cochrain databases was performed, and the latest publications on the problem of GE with an emphasis on AGE were studied using the keyword "atypical endometrial hyperplasia".

Results. The study presents a morphological classification of endometrial hyperplasia and shows a modern understanding of the progression of different nosological forms of this pathology. It is noted that endometrial hyperplasia is a clinical and morphological diagnosis based on anamnestic data, complex clinical and instrumental research and competent interpretation of morphological results.

Conclusion. Morphological analysis is the most precise method for diagnosing different types of endometrial hyperplasia, provided that the surgical material is collected correctly. The histological structure and changes at the cellular level are assessed Only on the basis of a comprehensive assessment is a final morphological conclusion made about the nature of the diagnosed pathological process. Perfect interpretation of histological material requires a highly qualified morphologist, as well as the availability of modern laboratory equipment. 

1. 1 Akusherstvo i ginekologiya: klinicheskie rekomendatsii. Pod red. G.M. Savel'evoy, V.N. Serova, G.T. Sukhikh. 4-e izd., pererab. i dop. Moscow: GEOTAR-Media. 2019:1008. (In Russ.).

2. 2 Bokhman Ya.V. Rukovodstvo po onkoginekologii. Saint Petersburg: Foliant. 2002:542. (In Russ.).

3. 3 Podzolkova N.M., Korennaya V.V. Modern concepts of the etiology, pathogenesis and principles of treatment of endometrial hyperplasia. Obstetrics and Gynecology. 2021;(8):192-199. (In Russ.). https://doi.org/10.18565/aig.2021.8.192-199

4. 4 Sviridova N.I., Tkachenko L.V., Yakhontova M.A., Gritsenko I.A., Maximov S.N., Puryaseva K.A. Endometrial hyperplastic processes: modern approaches to diagnosis and treatment. Akusherstvo, Ginekologia i Reprodukcia = Obstetrics, Gynecology and Reproduction. 2024;18(1):83–95. (In Russ.). https://doi.org/10.17749/23137347/ob.gyn.rep.2023.464

5. 5 Sherman M. E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Pathol. 2000;13(3):295-308.

6. 6 Ginekologiya. Natsional'noe rukovodstvo. 2-e izd., pererab. i dop. Pod redaktsiey G.M. Savel'evoy, G.T. Sukhikh, V.N. Serova, V.E. Radzinskogo, I.B. Manukhina. Moscow: GEOTAR-Media. 2017:1008. (In Russ.).

7. 7 Giperplaziya endometriya. Kodirovanie po Mezhdunarodnoy statisticheskoy klassifikatsii bolezney i pro-blem, svyazannykh so zdorov'em: N85.0, N85.1: klinicheskie rekomendatsii. Rossiyskoe obshchestvo akusherov-ginekologov; NP Sovet Minzdrava RF. Moskva, 2021. (In Russ.). URL: https://cr.minzdrav.gov.ru/schema/646_1

8. 8 Gabidullina R.I., Smirnova G.A., Nuhbala F.R. et al. Hyperplastic processes of the endometrium: modern tactics of patient management. Gynecology. 2019;21(6):53–58. (In Russ.). https://doi.org/10.26442/20795696.2019.6.190472

9. 9 Dobrokhotova Yu.E., Saprykina L.V. Giperplaziya endometriya. 2-e izd., pererab. i dop. Moscow: GEOTAR-Media. 2019:112. (In Russ.).

10. 10 Salamova K.K., Saprykina L.V., Ramazanova A.M. et al. Clinical characteristics of women with endometrial hyperplasia. Russian Journal of Woman and Child Health. 2021;4(2):124-129. (In Russ.). https://doi.org/10.32364/26188430-2021-4-2-124-129

11. 11 Novikova E.G., Chulkova O.V., Pronin S.M. Predrak i nachal'nyy rak endometriya u zhenshchin reproduktivnogo vozrasta. Moscow: MIA. 2005:136. (In Russ.).

12. 12 Rak endometriya. Pod red. I.V. Berleva, L.M. Bershteyna, A.F. Urmancheevoy. Saint Petersburg: Eko-Vektor. 2017:263. (In Russ.).

13. 13 Kondrikov N.I., Barinova I.V. Patologiya matki. Rukovodstvo dlya vrachey. Moscow: Prakticheskaya meditsina. 2019:352. (In Russ.).

14. 14 Medvedeva Yu.A., Kazachkov E.L., Kazachkova E.A. Morphometric characteristicsendometrial intraepithelial neoplasiain hyperplastic endometrium. Ural Medical Journal. 2014;8(122):97-101. (In Russ.).

15. 15 Opukholi tela i sheyki matki. Morfologicheskaya diagnostika i genetika: rukovodstvo dlya vrachey. Pod red. Yu.Yu. Andreevoy, G.A. Franka. Moscow: Prakticheskaya meditsina. 2015:304. (In Russ.).

16. 16 Khmel'nitskiy O.K. Tsitologicheskaya i gistologicheskaya diagnostika zabolevaniy sheyki i tela matki: rukovod-stvo. Saint Petersburg: Sotis. 2000:332. (In Russ.).

17. 17 Mutter G.L., Robboy S.J. Approaches to Precancerous and Metaplastic Endometrium. Boston: Harvard Medical School. 2005:235.

18. 18 Ayhan A., Reed N., Gultekin М., Dursun P. Textbook of gynaecological oncology. Gunes Publ. 2011:1138.

19. 19 Kogan E.A., Stanoevich I.V., Kudrina E.A., Ishchenko A.I. Morphological and immunohistochemical parallels in endometrial hyperplasia. Archives of pathology. 2007;(6):21-24. (In Russ.).

20. 20 Podgornaya A.S., Zakharko A.Yu., Shibaeva N.N. i dr. Proliferativnye protsessy endometriya: sovremennoe so-stoyanie problemy. Gomel': GU «RNPTs RM i ECh». 2018:33. (In Russ.).

21. 21 Mutter G.L., Zaino R.J., Baak J.P. et al. The benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int. J. Gynecol. Pathol. 2007;26:103-114.

22. 22 Lokuhetty D., White V.A., Watanabe R.L. Internal Agency for Research on Cancer (IARC). Female Genital Tumours. WHO Classification of Tumours Editorial Board. 5th ed. 2020.

23. 23 Mutter G.L. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol. Oncol. 2000;76(3):287-290.

24. 24 Grigorenko A.N., Gordiychuk A.B. Endometrial hyperplasia: more questions than answers. Reproductive endocrinology. 2017;3(35):31-43. (In Russ.).

25. 25 Orazov M.R., Mikhaleva L.M., Mullina I.A. Endometrial hyperplasia: a modern view of the problem. Obstetrics and Gynecology: news, opinions, training. 2022;10(3):62-67. (In Russ.).

26. 26 ACOG Committee Opinion No. 631. Endometrial intraepithelial neoplasia. Obstet. Gynecol. 2015;125(5):1272–1278. (In Russ.).

27. 27 Damirov M.M., Gus'kova O.N., Lavrent'eva I.A. Rezul'taty morfologicheskogo issledovaniya. Giperplaziya endometriya. Moscow: GEOTAR-Media. 2023:138-143. (In Russ.).

28. 28 Giannella L., Carpini G.D., Sopracordevole F. et al. Atypical endometrial hyperplasia and unexpected cancers at final histology: a study on endometrial sampling methods and risk factors. Diagnostics (Basel). 2020;10(7):474. https://doi.org/10.3390/diagnostics10070474

29. 29 The American College of Obstetricians and Gynecologists Committee Opinion no. 631. Endometrial intraepithelial neoplasia. Obstet. Gynecol. 2015;125(5):1272-1278.

30. 30 Ryan A.J., Susil B., Jobling T.W., Oehler M.K. Endometrial cancer. Cell Tissue Res. 2002;322(1):53-61. https://doi.org/10.1007/s00441-0051109-5

31. 31 Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. International Journal of Gynaecology and Obstetrics. 2018;143(3):393-408. https://doi.org/10.1002/ijgo.12666

32. 32 Emons Т., Beckmann M.W., Schmidt D., Mallmann P. New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015;75(2):135-136.

33. 33 WHO Classification of Tumours of Female Reproductive Organs. Eds. R.J. Kurman, M.L. Carcangiu, C.S. Herrington, R.H. Young. WHO Classification of Tumours, 4th Edition. Lyon: International Agency for Research on Cancer. 2014:307.

34. 34 Dolgikh V.T. Opukholevyy rost (izbrannye lektsii). Moscow: Meditsinskaya kniga; Nizhniy Novgorod: NGMA. 2001:78. (In Russ.).

35. 35 Kantserogenez. Pod red. D.G. Zaridze. Moscow: Meditsina. 2004:576. (In Russ.).

36. 36 Lyzhko N.A. Molecular-genetic mechanisms of initiation, promotion and progression of tumors. Russian Journal of Biotherapy. 2017;16(4):7-17. (In Russ.). https://doi.org/10.17650/1726-9784-2017-16-4-7-17

37. 37 Foulds L. Neoplastic development. New York: Academic Press. 1975;2:729.

38. 38 Shabad L.M. Predrak v eksperimental'no-morfologicheskom aspekte. Moscow: Meditsina. 1967:384. (In Russ.).

39. 39 Kryzhanovskiy G.N. Dizregulyatornaya patologiya. Moscow: Prakticheskaya meditsina. 2002:630. (In Russ.).

40. 40 Savel'eva G.M., Serov V.N. Predrak endometriya. Moscow: Meditsina. 1980:168. (In Russ.).

41. 41 Nikonov A.A. O raznoglasiyakh pri gistologicheskoy diagnostike giperplasticheskikh sostoyaniy i onkologiche-skoy patologii endometriya. Voprosy onkologii. 1990;36(9):1071-1076. (In Russ.).